Prolactinomas and pregnancy

Pituitary

Volumn 8, Issue 1, 2005, Pages 31-38

  Bronstein, Marcello Delano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bromocriptine; Cabergoline; Pituitary tumors; Pregnancy; Prolactin; Prolactinomas

Indexed keywords

BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CABERGOLINE; CONTRACEPTIVE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; QUINAGOLIDE; AMINOQUINOLINE DERIVATIVE; ERGOLINE DERIVATIVE;

ARTICLE; BREAST FEEDING; CONGENITAL MALFORMATION; DISEASE COURSE; DRUG CHOICE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HEADACHE; HUMAN; HYPOPITUITARISM; MULTIPLE PREGNANCY; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROLACTINOMA; SPONTANEOUS ABORTION; SYMPTOM; TUMOR GROWTH; TUMOR VOLUME; VISUAL FIELD; VISUAL SYSTEM EXAMINATION; CHILD; HYPOPHYSIS TUMOR; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; REVIEW;

AMINOQUINOLINES; BROMOCRIPTINE; CHILD; DOPAMINE AGONISTS; ERGOLINES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PROLACTINOMA;

EID: 33644870007     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-005-5083-4     Document Type: Article

References (60)

1. Burrow GN, Wortzman G, Rewcastle HB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy. N Engl J Med 1981; 304: 156.
2. Hardy J. Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO and Ross GT (eds.), Diagnosis and treatment of Pituitary Tumors, Amsterdam: Excerpta Medica, 1973, p. 179.
3. Miyai K, Ichihara K, Kondo K, Mori S. Asymptomatic hyperprolactinaemia and prolactinoma in the general population-mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf) 1986; 25: 549-554.
4. Hardy J. Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 1969; 16: 185-217.
5. Marino R Jr, Bronstein MD. The role of pituitary surgery in the treatment of prolactinomas. In: Meireles RMR, Machado A, Póvoa LC (eds.), Clinical Endocrinology: Proceedings of the 18th Brazilian Congress of Endocrinology and Metabolism, Rio de Janeiro, Junho, 1988, pp. 12-17. Amsterdam-New York-Oxford Excepta Medica. 1988, pp. 53-56.
6. Molitch ME. Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 1999; 28: 143-169.
7. Berezin M, Avidan D, Baron E. Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dipaminergic drugs. Isr J Med Sci 1991; 27: 375-379.
8. Webster J. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 1996; 14: 228-238.
9. Musolino NRC, Cunha Neto MB, Bronstein MD. Cabergoline as an alternative for medical treatment of prolactinomas: Experience in bromocriptine intolerance/resistance. Arq Bras Endocrinol Metab 2000; 44: 139-143.
10. Colao A, Di Sarno A, Sarnacchiaro F, Ferone D, Di Renzo G, Merola B, Annunziato L, Lombardi G. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 1997; 82: 876-883.
11. Duranteau L, Chanson P, Lavoinne A, Horlait S, Lubetzki J, Kuhn JM. Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas. Clin Endocrinol (Oxf) 1991; 34: 25-29.
12. Verhelst J, Abs R, Maiter D, van der Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A. Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 1999; 784: 2518-2522.
13. Cannavo S, Curto L, Squadrito S, Almoto B, Vieni A, Trimarchi F. Cabergoline: A first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. J Endocrinol Invest 1999; 22: 354-359.
14. Bronstein MD, Musolino NR, Benabou S, Marino R Jr. Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas. Surg Neurol 1989; 32: 346-349.
15. Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchell L, McNair H, Thomas DG, Robinson S, Johnston DG. Stereotactic conformal radiotherapy for pituitary adenomas: Technique and preliminary experience. Clin Endocrinol (Oxf) 2000; 52: 695-702.
16. Inoue HK, Kohga H, Hirato M, Sasaki T, Shihara J, Shibazaki T, Ohye C, Andou Y. Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: Experience in 122 cases. Stereotact Funct Neurosurg 1999; 72: 125-131.
17. Morange-Ramos I, Regis J, Dufor H, Andrieu JM, Grisoli F, Jaquet P, Peragaut JC. Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotact Funct Neurosurg 1998; 70: 127-138.
18. Elster AD, Sanders TG, Vines FS, Chen MY. Size and shape of the pituitary gland during pregnancy and post partum: Measurement with MR imaging. Radiology 1991; 181: 500-531.
19. Dinc H, Esen F, Demirci A, Sari A, Resit Gumele H. Pituitary dimensions and volume measurements in pregnancy and post partum M R assessment. Acta Radiol 1998; 39: 64-69.
20. Gonzalez JG, Elizondo G, Saldriar D, Nanez H, Todd LE, Vielarreal JZ. Pituitary gland growth during normal pregnancy: An in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217-220.
21. Scheithauer BW, Sano T, Kovacs KT, Young WFJr, Ryan N, Randall RV. The pituitary gland in pregnancy: A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990; 65: 461-474.
22. Rigg LA, Lein A, Yen SSC. Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol 1977; 129: 454-456.
23. Ferriani RA, Silva de Sá MF, Lima Filho EC. A comparative study of longitudinal and cross-sectional changes in plasma levels of prolactin and estriol during normal pregnancy. Brazilian J Med Biol Res 1986; 19: 183-188.
24. Zegher F, Spitz B, Van der Berghe G, Lemmens D, Vanweser K, Keppens K, Bowers CY. Postpartum hyperprolactinemia and hyporesponsiveness of growth hormone to GH-releasing peptide. J Clin Endocrinol Metab 1998; 83: 103-106.
25. Delvoye P, Delogne-Desnoeck J, Robyn C. Hyperprolactinaemia during prolonged lactation: Evidence for anovulatory cycles and inadequate corpus luteum. Clin Endocrinol 1980; 13: 243-247.
26. Gemzell C, Wang CF. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363-372.
27. Krupp P, Monka C. Bromocriptine in Pregnancy: Safety Aspects. Klin Wochenschr 1987; 65: 823-827.
28. Weil C. The safety of bromocriptine in long-term use: A review of the literature. Curr Res Opin 1986; 10: 25-51.
29. Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. Program of the Second Word Congress of Gynecology and Obstetrics, Rio de Janeiro, Brazil, 1988.
30. Chiodini I, Liuzzi A. PRL-secreting adenomas in pregnancy. J Endocrinol Invest 2003; 96-99.
31. Musolino NRC, Bronstein MD. Prolactinomas and Pregnancy. In: Bronstein MD (ed.), Pituitary Tumors in Pregnancy. Boston, Kluwer Academic Publishers, 2001, pp. 91-108.
32. Molitch ME. Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985; 312: 1364-1370.
33. Ferrer-Barriendos J, Millet A, Lucas-Pinilla E. Necrosis de un prolactinoma durante el embarazo. Rev Esp Obst Gin 1981; 40: 578-585.
34. Holmgren U, Bergstrand G, Hagenfeldt K, Werner S. Women with prolactinoma - effect of pregnancy and lactation on serum prolactin and on tumour growth. Acta Endocrinol (Copenh) 1986; 111: 452-459.
35. Shewchuk AB, Adamson GD, Lessard P, Ejrin C. The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea. Am J Obstet Gynecol 1980; 136: 659-666.
36. Child DF, Gordon H, Mashiter K, Jopkin GF. Pregnancy, prolactin, and pituitary tumours. Br Med J 1975; 4: 87-89.
37. van Roon E, van der Vijver JCM, Gerretsen G, Hekster REM, Wattendorff RA. Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil and Steril 1981; 36: 173-177.
38. Maeda T, Ushiroyama T, Okuda K, Fujimoto A, Ueki M, Sugimoto O. Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy. Obstet Gynecol 1983; 61: 117-120.
39. Brodsky JB, Cohen EN, Brown BW Jr, Wu ML, Whitcher C. Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 1980; 138: 1165-1167.
40. Bergh T, Nillius SJ, Wide L. Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours. Br Med J 1978; 1: 875-880.
41. Tan SL, Jacobs HS. Rapid regression through bromocriptine therapy of a suprasellar extending prolactinoma during pregnancy. Int J Gynaecol Obstet 1986; 24: 209-215.
42. Canales ES, Garcia IC, Ruiz JE, Zarate A. X Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil and Steril 1986; 36: 524-526.
43. Konopka P, Raymond JP, Merceron RE, Seneze J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983; 146: 935-938.
44. Molitch ME. Pituitary diseases in pregnancy. Semin Perinatol 1998; 22: 457-470.
45. Morange I, Barlier A, Pellegrini I, Brue T, Enjalbert A, Jaquet P. Prolactinomas resistant to bromocriptine: Long-term efficacy of quinagolide and outcome of pregnancy. Eur J Endocrinol 1996; 135: 413-420.
46. Robert E, Musatti L, Piscitelli G, Ferrari CI. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 1996; 10: 333-337.
47. Cannavo S, Curto L, Squadrito S, et al. Cabergoline: A first-choice treatment in patients with previously untreated prolactin-secreting pituitary adenoma. J Endocrinol Invest 1999; 22: 354-359.
48. Verhelst J, Abs R, Maiter D, et al. Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients. J Clin Endocrinol Metab 1999; 84: 2518-2522.
49. Ricci E, Parazzini F, Motta T, Ferrari CI, Colao A, et al. Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 2002; 16: 791-793.
50. Liu C, Tyrrell JB. Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. Pituitary 2001; 4: 179-185.
51. Bronstein MD, Salgado LR, Musolino NR. Medical management of pituitary adenomas: The special case of the pregnant woman. Pituitary 2002; 5: 99-107.
52. Zárate A, Canales ES, Alger M, Forsbach G. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours. Acta Endocrinol (Copenh) 1979; 92: 407-412.
53. Bronstein MD, Musolino NR, Cardim CS, Marino R Jr. Outcome of 52 pregnancies in hyperprolactinemic women. Rev Bras Ginecol Obstet 1988; 10: 175-178.
54. Bronstein MD, Musolino NR, Cardim C, Monteiro M, Marino RJr. Repeatable depot-bromocriptine treatment for prolactinomas. In: Meireles RMR, Machado A, Póvoa LC (eds.), Clinical Endocrinology: Proceedings of the 18th Brazilian Congress of Endocrinology and Metabolism, Rio de Janeiro, 1988;Junho pp. 12-17, Amsterdam-New York-Oxford: Excepta Medica. 1988, pp. 45-48.
55. Crosignani PG, Mattei AM, Severini V, Cavioni V, Maggioni P, Testa G. Long-term effects of time, medical treatment and pregnancy in 176 hyperprolactinemic women. Eur J Obstet Gynecol Reprod Biol 1992; 44: 175-180.
56. Rjosk HK, Fahlbusch R, von Werder K. Influence of pregnancies on prolactinomas. Acta Endocrinol (Copenh) 1982; 100: 337-346.
57. Badawy SZ, Marziale JC, Rosenbaum AE, Chang JK, Joy SE. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas - the value of radiologic studies. Early Pregnancy 1997; 3: 306-311.
58. Ahmed M, al-Dossary E, Woodhouse NJ. Macroprolactinomas with suprasellar extension: Effect of bromocriptine withdrawal during one or more pregnancies. Fertil Steril 1992; 58: 492-497.
59. Peillon F, Racadot J, Moussy D, Vila-Porcile E, Olivier L, Racadot O. Prolactin-secreting adenomas. A correlative study of morphological and clinical data. In: Fahlbusch R., Von Werder K. (eds.), Treatament of pituitary adenomas. Stuttgart: Thiemi, 1978, pp. 114.
60. Freeman R, Wezenter B, Silvestein M, Kuo D, Weiss KL, Kantrowitz AB, Schubart UK. Pregnancy-associated subacute hemorrhage into a prolactinoma resulting in diabetes insipidus. Fertil Steril 1992; 58: 427-429.